Radiation Biology Needs Physicians

The world faces a growing deficiency in the number of medical scientists who are well informed about the delayed effects of ionizing radiation. This deficiency is growing because the physicians who entered the field in the early 1950s are now reaching retirement age. No one is following them because career opportunities in human radiation biology have become less appealing than those in other fields. The excitement about research in radiation biology has diminished over the years since the dropp

Written byRobert Miller
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Yet the world continues to need such scientists. Studies following the Chernobyl accident illustrate how an oversight may occur from incomplete knowledge of the literature. In their study of intrauterine effects, the Soviets concentrated on severe mental retardation, which had been the focus in the recent medical literature. I was a member of a U.S. delegation on nuclear safety that visited the Soviet Union following the Chernobyl accident. During a briefing at the Ministry of Health for the Ukraine, we learned that the Soviets had noted no differences between exposed and unexposed newborns. We also discovered that although they had made body measurements of the newborn infants, they apparently had not analyzed head size in relation to exposure dose. In Japan, small head circumference in newborns occurred at lower doses and, over the full dose range, was four to six times more common than was severe mental retardation among those ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies